Insiders · Profile

Powell David Jonathan

Chief Scientific Officer at Summit Therapeutics. Filing since 23 Nov 2020. CIK 0001824493

Company
Date
Role
Action
Shares
Amount
Of holding
30 Nov 2020
Chief Scientific Officer
Sold, plan not stated
13,713
$60.89K
100%
27 Nov 2020
Chief Scientific Officer
Sold, plan not stated
29,569
$129.81K
100%
25 Nov 2020
Chief Scientific Officer
Sold, plan not stated
12,070
$52.14K
100%
24 Nov 2020
Chief Scientific Officer
Sold, plan not stated
11,374
$47.88K
100%
23 Nov 2020
Chief Scientific Officer
Sold, plan not stated
6,987
$30.74K
100%
5 decisions on file.